A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type ...

Research shows diabetes medications may cut Alzheimer's risk by up to 43% in patients with type 2 diabetes, offering ...

It’s possible that they may play a role as a preventative measure in the future,” said Dr. Catriona Reddin told The Post.

Researchers used data from more than 92,000 people with type 2 diabetes. They found that two medications significantly ...

Technologies like genomics, neuroimaging, and biomarker analysis drive growth. The Alzheimer’s drugs market is expected to ...

Results were drawn from assessments collected during the trials' six-month follow-up periods. According to their findings, patients taking GLP-1 drugs saw a 45 percent decreased risk of developing ...

Two new studies published in JAMA Neurology reveal that GLP-1 receptor agonists, like Ozempic and Trulicity, may ...

The purpose of black box warnings is to draw immediate attention to the most serious potential adverse effects of a drug, ...

1:54 GLP-1 drugs like Ozempic, Wegovy reduce Alzheimer’s risk for those with diabetes Two major studies published Monday in JAMA Neurology found that GLP-1 medications are linked to a lower risk ...

Looking at 400,000 Medicare beneficiaries who used the drugs, the research found that men in the group who had taken the ...